Measles vaccine study for children with sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study checks if the measles vaccine works well in children with sickle cell disease. It aims to help protect children with this condition from measles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child has sickle cell disease.
- Your child is between 6 months and 6 years old and needs a measles vaccine within the next 3 months.
- You are willing and able to provide consent for your child to join.
- Your child can attend study visits and follow-up appointments.
- Your child does not have a weak immune system (like from cancer, AIDS, or a primary immune disorder) that would prevent them from getting a live vaccine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a new pneumococcal vaccine (21-valent) in children and teens with sickle cell disease. It aims to see if the vaccine can help protect against serious infections caused by pneumococcus bacteria, which are especially dangerous for people with SCD.
This study looks at how severe dengue fever affects people with sickle cell disease. It aims to understand why some people with sickle cell get very sick from dengue and how their cells react.
This early-phase study tests whether a “half-matched” donor bone marrow transplant, with special medicines to calm the immune system before transplant, can improve outcomes for people with sickle cell disease. It may help high-risk patients who have frequent complications and don’t have a fully matched donor.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
This trial tests a “biochip” device using samples from people with sickle cell disease. If it works, it may help doctors study sickle cell biology more accurately using patient samples.
This study looks at how hydrated your skin is in people with sickle cell disease. It aims to better understand skin-related changes, which may help doctors monitor health and treatments in the future.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.